Cargando…

Cancer Proteomics: The State of the Art

Now that the human genome has been determined, the field of proteomics is ramping up to tackle the vast protein networks that both control and are controlled by the information encoded by the genome. The study of proteomics should yield an unparalleled understanding of cancer as well as an invaluabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrmann, Paul C., Liotta, Lance A., Petricoin III, Emanuel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851073/
https://www.ncbi.nlm.nih.gov/pubmed/11673651
http://dx.doi.org/10.1155/2001/327047
_version_ 1782294219012964352
author Herrmann, Paul C.
Liotta, Lance A.
Petricoin III, Emanuel F.
author_facet Herrmann, Paul C.
Liotta, Lance A.
Petricoin III, Emanuel F.
author_sort Herrmann, Paul C.
collection PubMed
description Now that the human genome has been determined, the field of proteomics is ramping up to tackle the vast protein networks that both control and are controlled by the information encoded by the genome. The study of proteomics should yield an unparalleled understanding of cancer as well as an invaluable new target for therapeutic intervention and markers for early detection. This rapidly expanding field attempts to track the protein interactions responsible for all cellular processes. By careful analysis of these systems, a detailed understanding of the molecular causes and consequences of cancer should emerge. A brief overview of some of the cutting edge technologies employed by this rapidly expanding field is given, along with specific examples of how these technologies are employed. Soon cellular protein networks will be understood at a level that will permit a totally new paradigm of diagnosis and will allow therapy tailored to individual patients and situations.
format Online
Article
Text
id pubmed-3851073
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38510732013-12-22 Cancer Proteomics: The State of the Art Herrmann, Paul C. Liotta, Lance A. Petricoin III, Emanuel F. Dis Markers Other Now that the human genome has been determined, the field of proteomics is ramping up to tackle the vast protein networks that both control and are controlled by the information encoded by the genome. The study of proteomics should yield an unparalleled understanding of cancer as well as an invaluable new target for therapeutic intervention and markers for early detection. This rapidly expanding field attempts to track the protein interactions responsible for all cellular processes. By careful analysis of these systems, a detailed understanding of the molecular causes and consequences of cancer should emerge. A brief overview of some of the cutting edge technologies employed by this rapidly expanding field is given, along with specific examples of how these technologies are employed. Soon cellular protein networks will be understood at a level that will permit a totally new paradigm of diagnosis and will allow therapy tailored to individual patients and situations. IOS Press 2001 2002-06-07 /pmc/articles/PMC3851073/ /pubmed/11673651 http://dx.doi.org/10.1155/2001/327047 Text en Copyright © 2001 Hindawi Publishing Corporation.
spellingShingle Other
Herrmann, Paul C.
Liotta, Lance A.
Petricoin III, Emanuel F.
Cancer Proteomics: The State of the Art
title Cancer Proteomics: The State of the Art
title_full Cancer Proteomics: The State of the Art
title_fullStr Cancer Proteomics: The State of the Art
title_full_unstemmed Cancer Proteomics: The State of the Art
title_short Cancer Proteomics: The State of the Art
title_sort cancer proteomics: the state of the art
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851073/
https://www.ncbi.nlm.nih.gov/pubmed/11673651
http://dx.doi.org/10.1155/2001/327047
work_keys_str_mv AT herrmannpaulc cancerproteomicsthestateoftheart
AT liottalancea cancerproteomicsthestateoftheart
AT petricoiniiiemanuelf cancerproteomicsthestateoftheart